home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  
 

registry of biomedical companies

 
  June 21, 2024
promoting the transfer of scientific know-how between industry and academia
 
 
Registry of biomedical companies:

[3] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 463 active entries

Biosynth Laboratories Limited (formerly Cambridge Research Biochemicals Ltd)

17-18 Belasis Court
Billingham
United Kingdom

Phone: +44 (0) 1642 567180
Fax: +44 (0) 1642 567181

Description:

Cambridge Research Biochemicals (CRB) was aquired by Biosynth in May 2023 and changed its name to Biosynth Laboratories Limited in June 2023. Biosynth Laboratories is a leading independent producer of custom-made peptide and antibody tools, supplying researchers in the pharmaceutical, life science and academic sectors worldwide. The primary applications of its products are as custom-made, laboratory scale reagents for proof of principle studies within early phase drug discovery and to support immunoassay and biomarker programmes in clinical studies. The company produces all flavours of peptides from simple to modified, stable and radio-labelled to dye labelled from milligrams to gram-scale to the highest levels of purity. Biosynth has an enviable track record for generating target specific polyclonal antibodies with modifications and labelling and Infinity antibodies: custom generated monoclonal antibodies to challenging antigens.
 
Biosynth also has an extensive catalogue of research products comprising: Peptides & Antibodies, Comples Chemicals (Carbohydrates, Enzymes) and Biologics.



Selected Categories:
Product Company   Service Company
Biopharma
- Research
Biotech
- Research
Diagnostics
- General
Pharmaceutical
- Research
Supplier
- Laboratory
- Research
Contract
- Services

Last update of this entry: September 12, 2023

   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2024 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.